2-nitroimidazole-1-methylacetohydroxamate has been researched along with Carcinoma, Epidermoid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tada, T | 1 |
| Abe, M; Iwai, H; Murata, R; Oya, N; Shibamoto, Y; Shibata, T; Sugiyama, T | 1 |
| Hori, H; Inayama, S; Mori, T; Murayama, C; Nagasawa, H; Nakajima, T; Onoyama, Y; Tada, T | 1 |
3 other study(ies) available for 2-nitroimidazole-1-methylacetohydroxamate and Carcinoma, Epidermoid
| Article | Year |
|---|---|
[Radiosensitizing effects of nitroimidazole derivative, KIN-804].
Topics: Animals; Carcinoma, Squamous Cell; Hydroxamic Acids; Male; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Skin Neoplasms | 1995 |
KIN-804 vs. KU-2285 as a radiosensitizer for clinical use.
Topics: Animals; Carcinoma, Squamous Cell; Chromosome Aberrations; Female; Humans; Hydroxamic Acids; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1994 |
In vivo radiosensitizing effect of nitroimidazole derivative KIN-804.
Topics: Animals; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Hydroxamic Acids; Lethal Dose 50; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1994 |